Cargando…
Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
Autores principales: | Lyons, Sarah K., Hermann, Julia M., Miller, Kellee M., Hofer, Sabine E., Foster, Nicole C., Rami-Merhar, Birgit M., Aleppo, Grazia, Seufert, Jochen, DiMeglio, Linda A., Danne, Thomas, Maahs, David M., Holl, Reinhard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463738/ https://www.ncbi.nlm.nih.gov/pubmed/28768688 http://dx.doi.org/10.2337/dc17-0403 |
Ejemplares similares
-
Effects of Frequency of Sensor-Augmented Pump Use on HbA(1c) and C-Peptide Levels in the First Year of Type 1 Diabetes
por: Triolo, Taylor M., et al.
Publicado: (2016) -
Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines
por: Wood, Jamie R., et al.
Publicado: (2013) -
The Evolution of Hemoglobin A(1c) Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
por: Redondo, Maria J., et al.
Publicado: (2021) -
Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
por: Foster, Nicole C., et al.
Publicado: (2016) -
A Decade of Disparities in Diabetes Technology Use and HbA(1c) in Pediatric Type 1 Diabetes: A Transatlantic Comparison
por: Addala, Ananta, et al.
Publicado: (2021)